Ravi Sarode, MD, is a Tenured Professor of Pathology and Internal Medicine (Hematology/Oncology), the Chief of Pathology, and the Medical Director of Clinical Laboratory Services at the University of Texas Southwestern Medical Center in Dallas. He is also the Medical Director of the Division of Transfusion Medicine and Hemostasis. He holds the John H. Childers, MD, Professorship in Pathology.
Dr. Sarode is a Co-Editor-in-Chief of Transfusion and Apheresis Science and sits on the editorial board of Transfusion Medicine Reviews. He is also the past president of the American Society for Apheresis (ASFA) and one of the original writers of the ASFA guidelines. He was also invited to write guidelines on anticoagulation reversal by the American Heart Association (2016-17) and the American College of Emergency Physicians (2018-2019), and on hemostasis and transfusion issues before any intervention by the Society for Interventional Radiology (2017-18). Additionally, he served on the Advisory Committee on Blood/Tissue Safety and Availability, advising the Secretary of Department of Health and Human Services of the United States.
Dr. Sarode’s research interests include thrombotic thrombocytopenic purpura, heparin-induced thrombocytopenia, therapeutic apheresis, with a focus on red cell exchange in sickle cell anemia, antiphospholipid antibody syndrome, platelet function disorders, reducing the misuse of blood products in clinical practice, prothrombin complex concentrates (PCCs), and rebalanced hemostasis in cirrhosis. He has published more than 200 original articles and book chapters, and has participated as a principal investigator for more than 12 clinical research studies, including a randomized controlled trial comparing an investigational four-factor PCC (Octaplex/Balfaxar) with an FDA-approved control four-factor PCC (Beriplex/Kcentra).
Dr. Sarode is passionate about educating clinicians on the appropriate use of blood components and laboratory testing to avoid patient harm, to use limited resources judiciously, and to reduce the healthcare costs.